181 related articles for article (PubMed ID: 18797459)
1. Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma.
Tabori U; Wong V; Ma J; Shago M; Alon N; Rutka J; Bouffet E; Bartels U; Malkin D; Hawkins C
Br J Cancer; 2008 Oct; 99(7):1129-35. PubMed ID: 18797459
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review.
Zawrocki A; Iżycka-Świeszewska E; Papierz W; Liberski PP; Zakrzewski K; Biernat W
Folia Neuropathol; 2011; 49(2):94-102. PubMed ID: 21845537
[TBL] [Abstract][Full Text] [Related]
3. Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.
Tabori U; Ma J; Carter M; Zielenska M; Rutka J; Bouffet E; Bartels U; Malkin D; Hawkins C
J Clin Oncol; 2006 Apr; 24(10):1522-8. PubMed ID: 16575002
[TBL] [Abstract][Full Text] [Related]
4. Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma.
Ridley L; Rahman R; Brundler MA; Ellison D; Lowe J; Robson K; Prebble E; Luckett I; Gilbertson RJ; Parkes S; Rand V; Coyle B; Grundy RG;
Neuro Oncol; 2008 Oct; 10(5):675-89. PubMed ID: 18701711
[TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibition as a novel therapy for pediatric ependymoma.
Wong VC; Morrison A; Tabori U; Hawkins CE
Brain Pathol; 2010 Jul; 20(4):780-6. PubMed ID: 20184588
[TBL] [Abstract][Full Text] [Related]
6. Current therapy and the evolving molecular landscape of paediatric ependymoma.
Khatua S; Ramaswamy V; Bouffet E
Eur J Cancer; 2017 Jan; 70():34-41. PubMed ID: 27866097
[TBL] [Abstract][Full Text] [Related]
7. Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma.
Rand V; Prebble E; Ridley L; Howard M; Wei W; Brundler MA; Fee BE; Riggins GJ; Coyle B; Grundy RG;
Br J Cancer; 2008 Oct; 99(7):1136-43. PubMed ID: 18781180
[TBL] [Abstract][Full Text] [Related]
8. Latest classification of ependymoma in the molecular era and advances in its treatment: a review.
Yamaguchi J; Ohka F; Motomura K; Saito R
Jpn J Clin Oncol; 2023 Jul; 53(8):653-663. PubMed ID: 37288489
[TBL] [Abstract][Full Text] [Related]
9. Pediatric ependymomas: will molecular biology change patient management?
Grill J; Bergthold G; Ferreira C
Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
[TBL] [Abstract][Full Text] [Related]
10. Adult ependymal tumors: prognosis and the M. D. Anderson Cancer Center experience.
Armstrong TS; Vera-Bolanos E; Bekele BN; Aldape K; Gilbert MR
Neuro Oncol; 2010 Aug; 12(8):862-70. PubMed ID: 20511182
[TBL] [Abstract][Full Text] [Related]
11. Management of Ependymoma in Children, Adolescents and Young Adults.
Thorp N; Gandola L
Clin Oncol (R Coll Radiol); 2019 Mar; 31(3):162-170. PubMed ID: 30616927
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Ependymoma.
Vitanza NA; Partap S
J Child Neurol; 2016 Oct; 31(12):1354-66. PubMed ID: 26503805
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology of paediatric central nervous system tumours.
Chiang JC; Ellison DW
J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
[TBL] [Abstract][Full Text] [Related]
14. ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.
Gilbertson RJ; Bentley L; Hernan R; Junttila TT; Frank AJ; Haapasalo H; Connelly M; Wetmore C; Curran T; Elenius K; Ellison DW
Clin Cancer Res; 2002 Oct; 8(10):3054-64. PubMed ID: 12374672
[TBL] [Abstract][Full Text] [Related]
15. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues.
Delgado-López PD; Corrales-García EM; Alonso-García E; García-Leal R; González-Rodrigálvarez R; Araus-Galdós E; Martín-Alonso J
Clin Transl Oncol; 2019 Nov; 21(11):1450-1463. PubMed ID: 30868390
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma.
Gojo J; Englinger B; Jiang L; Hübner JM; Shaw ML; Hack OA; Madlener S; Kirchhofer D; Liu I; Pyrdol J; Hovestadt V; Mazzola E; Mathewson ND; Trissal M; Lötsch D; Dorfer C; Haberler C; Halfmann A; Mayr L; Peyrl A; Geyeregger R; Schwalm B; Mauermann M; Pajtler KW; Milde T; Shore ME; Geduldig JE; Pelton K; Czech T; Ashenberg O; Wucherpfennig KW; Rozenblatt-Rosen O; Alexandrescu S; Ligon KL; Pfister SM; Regev A; Slavc I; Berger W; Suvà ML; Kool M; Filbin MG
Cancer Cell; 2020 Jul; 38(1):44-59.e9. PubMed ID: 32663469
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and treatment options for paediatric ependymomas.
Vaidya K; Smee R; Williams JR
J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
[TBL] [Abstract][Full Text] [Related]
19. SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
Ritzmann TA; Chapman RJ; Kilday JP; Thorp N; Modena P; Dineen RA; Macarthur D; Mallucci C; Jaspan T; Pajtler KW; Giagnacovo M; Jacques TS; Paine SML; Ellison DW; Bouffet E; Grundy RG
Neuro Oncol; 2022 Jun; 24(6):936-948. PubMed ID: 35018471
[TBL] [Abstract][Full Text] [Related]
20. A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma.
Sabnis DH; Storer LCD; Liu JF; Jackson HK; Kilday JP; Grundy RG; Kerr ID; Coyle B
Sci Rep; 2019 Jul; 9(1):10290. PubMed ID: 31311995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
